Toll Free: 1-888-928-9744

Indian Immunologicals Limited - Product Pipeline Review - 2014

Published: Oct, 2014 | Pages: 30 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Indian Immunologicals Limited - Product Pipeline Review - 2014

Summary

Global Markets Direct's, 'Indian Immunologicals Limited - Product Pipeline Review - 2014', provides an overview of the Indian Immunologicals Limited's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Indian Immunologicals Limited's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Indian Immunologicals Limited including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Indian Immunologicals Limited's human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Indian Immunologicals Limited's pipeline products

Reasons to buy

- Evaluate Indian Immunologicals Limited's strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Indian Immunologicals Limited in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Indian Immunologicals Limited's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Indian Immunologicals Limited and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Indian Immunologicals Limited
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Indian Immunologicals Limited and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
 Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Indian Immunologicals Limited Snapshot 5
Indian Immunologicals Limited Overview 5
Key Information 5
Key Facts 5
Indian Immunologicals Limited - Research and Development Overview 6
Key Therapeutic Areas 6
Indian Immunologicals Limited - Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products - Monotherapy 10
Indian Immunologicals Limited - Pipeline Products Glance 11
Indian Immunologicals Limited - Clinical Stage Pipeline Products 11
Phase I Products/Combination Treatment Modalities 11
Indian Immunologicals Limited - Early Stage Pipeline Products 12
Preclinical Products/Combination Treatment Modalities 12
Indian Immunologicals Limited - Unknown Stage Pipeline Products 13
Unknown Products/Combination Treatment Modalities 13
Indian Immunologicals Limited - Drug Profiles 14
chikungunya vaccine 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
DPT-H-HiB Vaccine 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
haemophilus influenzae vaccine [type B] 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
human papilloma virus vaccine [types 16 and 18] 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
alphavirus vaccine 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
flavivirus vaccine 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
Japanese encephalitis vaccine 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
picornavirus vaccine 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
vaccine for cervical cancer 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
Vaccine for Undisclosed Indication 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
Indian Immunologicals Limited - Pipeline Analysis 24
Indian Immunologicals Limited - Pipeline Products by Route of Administration 24
Indian Immunologicals Limited - Pipeline Products by Molecule Type 25
Indian Immunologicals Limited - Dormant Projects 26
Indian Immunologicals Limited - Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Appendix 29
Methodology 29
Coverage 29
Secondary Research 29
Primary Research 29
Expert Panel Validation 29
Contact Us 30
Disclaimer 30
List of Tables
Indian Immunologicals Limited, Key Information 5
Indian Immunologicals Limited, Key Facts 5
Indian Immunologicals Limited - Pipeline by Indication, 2014 8
Indian Immunologicals Limited - Pipeline by Stage of Development, 2014 9
Indian Immunologicals Limited - Monotherapy Products in Pipeline, 2014 10
Indian Immunologicals Limited - Phase I, 2014 11
Indian Immunologicals Limited - Preclinical, 2014 12
Indian Immunologicals Limited - Unknown, 2014 13
Indian Immunologicals Limited - Pipeline by Route of Administration, 2014 24
Indian Immunologicals Limited - Pipeline by Molecule Type, 2014 25
Indian Immunologicals Limited - Dormant Developmental Projects,2014 26
Indian Immunologicals Limited, Other Locations 27 



                                

To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $1500
Multi User - US $3000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify